Work

Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study

Year: 2018

Type: article

Study design: Clinical Trial

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2018.07.004

Authors: Mamta Parikh, Chong-Xian Pan, Laurel A. Beckett, Yueju Li, Daniel A. Robles, Pawandeep K. Aujla, Primo N. Lara

Institutions: University of California Davis Medical Center, UC Davis Comprehensive Cancer Center, University of California, Davis

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Veterans Affairs, National Cancer Institute

Awards: G1596171759, G1679550197, G776903742, G8132368549

OpenAlex ID: W2884947885

FWCI: 1.655

Cites: 24

Cited by: 12

Related to: 10